Marijn de Bruin
About Marijn de Bruin
Hiv treatment adherence; Design and evaluation of theory- and evidence-based health communication/behaviour change programs; Intention-behavior gap; Taxonomy of communication techniques; Assessment and impact of health communication in health care settings; Adherence to lifestyle recommendations; Qualitative and quantitative research methods; Meta-analyses; Bias in self-reports and trials; Chronic diseases; Capacity building; behaviours change counseling
Role(s) / Profession(s)
- Academic
Organization
- University of Amsterdam
Work Location(s)
- Netherlands
Language(s)
- Dutch
- English
Marijn's Communities
Recent Contributions
-

Marijn de Bruin replied to "Long acting antiretroviral medications for treatment and prevention" in the HIV Treatment & Prevention community.
Hi all, I think this could be a very promising development indeed. A few thoughts I had reading the discussion: First, I think this should be considered as an additional strategy, something that patients can choose, rather than something that is implemented because we assume that is better. This sounds ...
-

Marijn de Bruin replied to "Member Spotlight: Marijn de Bruin - is adherence care under threat?" in the HIV Treatment & Prevention community.
Another member (Pamela Sparks) just posted a paper relevant to this discussion. See http://www.ghdonline.org/uploads/Timeliness_of_Clinical_appointments_as_predicator_of_virological_response.pdf Best wishes, Marijn
-

Marijn de Bruin replied to "Member Spotlight: Marijn de Bruin - is adherence care under threat?" in the [ARCHIVED] Adherence & Retention community.
Another member (Pamela Sparks) just posted a paper relevant to this discussion. See http://www.ghdonline.org/uploads/Timeliness_of_Clinical_appointments_as_predicator_of_virological_response.pdf Best wishes, Marijn
-

Marijn de Bruin replied to "Member Spotlight: Marijn de Bruin - is adherence care under threat?" in the HIV Treatment & Prevention community.
Ps. I forgot to mention this 80-90% is for those patient still in care. Although better support at treatment start should reduce dropout of care rates later, it is a different effort altogether to keep those struggling with HIV treatment acceptance, stigma, and so forth in care over the years. ...
-

Marijn de Bruin replied to "Member Spotlight: Marijn de Bruin - is adherence care under threat?" in the [ARCHIVED] Adherence & Retention community.
Ps. I forgot to mention this 80-90% is for those patient still in care. Although better support at treatment start should reduce dropout of care rates later, it is a different effort altogether to keep those struggling with HIV treatment acceptance, stigma, and so forth in care over the years. ...
Recent Recommendations
- None at this time.
